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Q: What is the CDC Surveillance Strategy? 
A: Launched in February 2014, the CDC Surveillance Strategy 
(http://www.cdc.gov/surveillance/) is a plan to improve the agency’s activities in public health 
surveillance. The strategy aims to improve CDC’s overall surveillance capabilities and, by 
extension, those of the public health system at large. The strategy guides efforts to make 
essential surveillance systems more adaptable to the rapidly changing technology landscape, 
more versatile in meeting demands for expanding knowledge about evolving threats to health, 
and more able to meet the demands for timely and population-specific and geographic-specific 
surveillance information. The strategy will also facilitate work to consolidate systems, eliminate 
unnecessary redundancies in reporting, and reduce reporting burden. 
 
The three major goals of the CDC Surveillance Strategy are to 
 
1. enhance the accountability, resource use, workforce, and innovation for surveillance 
at CDC and in support of state, tribal, local, and territorial (STLT) agencies;  
2. accelerate the utilization of emerging tools and approaches to improve the 







3. through cross-cutting agency initiatives, improve surveillance by addressing data 
availability, system usability, redundancies, and incorporation of new information 
technologies in major systems or activities. 
 
The National Notifiable Diseases Surveillance System (NNDSS) Modernization Initiative (NMI) is 
one of four initiatives to address goal number three. 
 
Q: What is the NNDSS Modernization Initiative? 
A: With the evolution of technology and data and exchange standards, CDC now has the 
opportunity to strengthen and modernize the infrastructure supporting the National Notifiable 
Diseases Surveillance System. As part of the CDC Surveillance Strategy, the NNDSS 
Modernization Initiative is underway to enhance the system’s ability to provide more 
comprehensive, timely, and higher quality data than ever before for public health decision 
making. Through this multi-year initiative, CDC seeks to increase the robustness of the NNDSS 
technological infrastructure so that it is based on interoperable, standardized data and 
exchange mechanisms. 
 
Q: What is the National Notifiable Diseases Surveillance System? 
A: The National Notifiable Diseases Surveillance System is a nationwide collaboration that 
enables all levels of public health—local, state, territorial, federal, and international—to share 
notifiable disease-related health information. Public health uses this information to monitor, 
control, and prevent the occurrence and spread of state-reportable and nationally notifiable 
infectious and noninfectious diseases and conditions.  
 
NNDSS is a multifaceted program that includes the surveillance system for collection, analysis, 
and sharing of health data. It also includes policies, laws, electronic messaging standards, 
people, partners, information systems, processes, and resources at the local, state, territorial, 
and national levels.  
 
Notifiable disease surveillance begins at the level of local, state, and territorial public health 
departments (also known as jurisdictions). Jurisdictional laws and regulations mandate 
reporting of cases of specified infectious and noninfectious conditions to health departments. 
The health departments work with healthcare providers, laboratories, hospitals, and other 
partners to obtain the information needed to monitor, control, and prevent the occurrence and 
spread of these health conditions. In addition, health departments notify CDC about the 
occurrence of certain conditions. 
 
The CDC Division of Health Informatics and Surveillance (DHIS) supports NNDSS by receiving, 
securing, processing, and providing nationally notifiable infectious diseases data to disease-
specific CDC programs. DHIS also supports local, state, and territorial public health departments 
in helping them collect, manage, and submit case notification data to CDC for NNDSS. DHIS 
provides this support through funding, health information exchange standards and frameworks, 







tools, and training. Together, DHIS and the CDC programs prepare annual summaries of 
infectious and noninfectious diseases and conditions, which are published in the CDC Morbidity 
and Mortality Weekly Report. 
 
CDC programs responsible for national surveillance, prevention, and control of infectious and 
noninfectious conditions are found in the  
• Center for Global Health (CGH); 
• National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP); 
• National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); 
• National Center for Environmental Health (NCEH); 
• National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); 
• National Center for Immunization and Respiratory Diseases (NCIRD); and 
• National Institute for Occupational Safety and Health (NIOSH). 
 
These programs collaborate with the Council of State and Territorial Epidemiologists (CSTE) to 
determine which conditions reported to local, state, and territorial public health departments 
are nationally notifiable. The CDC programs, in collaboration with subject matter experts in 
CSTE and in health departments, determine what data elements are included in national 
notifications. Health departments participating in NNDSS voluntarily submit infectious disease 
data to DHIS and also submit some data directly to CDC programs. 
 
Q: Who is leading NMI? 
A: NMI is a CDC-wide effort. The NMI team in DHIS, CSELS, is leading the development of the 
health information infrastructure needed to support NNDSS. Currently, the NMI team is 
working hand-in-hand with subject matter experts in programs from the CDC Office of 
Infectious Diseases (OID), who are leading the effort to develop disease-specific data elements 
for new Message Mapping Guides (MMGs) for Health Level 7 (HL7) –formatted disease case 
notification.  
 
The NMI team also is working with the Association of Public Health Laboratories (APHL), CSTE, 
and pilot jurisdictions to strengthen the NMI effort by their input on NMI processes and 
deliverables, such as message mapping guides. APHL also is helping to develop, pilot, and refine 
the technical assistance needed to implement HL7 case notification messages in jurisdictions. In 
addition, CSTE is helping to evaluate the NMI effort through jurisdiction feedback and to 
develop and distribute communication messages to jurisdictions. 
 
Q: What are the key components of NMI? 
A: NMI has three key components:  
1. development of prioritized Message Mapping Guides for HL7 case notifications;  
2. development of the Message Validation, Processing, and Provisioning System 
(MVPS), software that will validate and process nationally notifiable disease data 







3. technical assistance for implementation of HL7 case notification messages in 
jurisdictions submitting case notifications to NNDSS. 
 
Q: How long will NMI last? 
A: The initiative to modernize NNDSS began in January 2014 and is planned for several years 
with short-term deliverables in the first phase and long-term activities in the following years. 
 
Q: What is the primary NMI short-term deliverable? 
A: In the first phase of NMI, CDC’s sexually transmitted diseases (STD), congenital syphilis, 
hepatitis, mumps, and pertussis programs—as well as programs representing 52 conditions 
covered by the Generic v2 Message Mapping Guide—are expected to receive timely, complete, 
and high-quality data from certain jurisdictions through the MVPS. As NMI progresses, CDC will 
increase the number of conditions and jurisdictions using HL7 messages and the MVPS for 
NNDSS. 
 
Q: What are the longer term activities for NMI? 
A: Longer term NMI activities include the following: 
• Continue development of MMGs and implementation of HL7 case notification 
messages. 
• Implement and enhance the MVPS, including developing and implementing other 
services and components of the MVPS. 
• Facilitate the use of standards and promote and encourage data element harmonization 
for surveillance of nationally notifiable conditions. 
• Retire the National Electronic Telecommunications System for Surveillance (NETSS). 
• Determine future direction of the National Electronic Disease Surveillance System 
(NEDSS) Base System (NBS). 
 
 




Q: Why is CDC developing new HL7 MMGs for NNDSS case notifications?  
A: CDC is developing new HL7 Message Mapping Guides to improve collection, transmission, 
and analysis of data needed at the national level for public health surveillance. In doing so, CDC 
is implementing messaging standards and vocabulary standards in case notifications. For some 
diseases and conditions, the epidemiology of the notifiable disease has changed over time and 
new data are needed about risk factors or new clinical information is needed, such as 
laboratory tests and results, vaccination information, and treatment information. For other 
nationally notifiable diseases, CDC previously received only generic data but also now needs 
disease-specific data. (Note that NETSS uses a proprietary data and vocabulary format and is 







Q: What is the difference between a Message Mapping Guide and an HL7 case notification 
message? 
A: A disease-specific Message Mapping Guide is similar to a data dictionary and indicates the 
data elements (generic or disease-specific) and the valid values for those data elements 
included in case notification messages. For example, in referring to the Hepatitis MMG, we are 
referring only to the disease-specific data elements that are included within the hepatitis 
message. In contrast, when we refer to a disease-specific HL7 case notification message, we are 
referring to both the generic data elements that are part of all case notification messages and 
the data elements specific to that disease. For example, in referring to a hepatitis HL7 case 
notification message (or hepatitis message), we are referring to both generic and disease-
specific data elements that, together, comprise the complete hepatitis HL7 case notification 
message. For this reason, we talk about implementing HL7 case notification messages and not 
about implementing MMGs. 
 
Q: What MMGs are currently being developed and why were they selected? 
A: The DHIS NMI team worked with subject matter experts in CDC programs to prioritize six 
MMGs for development. The first set of guides address the generic data elements that will be 
included in all messages as well as the disease-specific data elements for STD, Hepatitis, 
Congenital Syphilis, Pertussis, and Mumps.  
 
Work has now begun on guides for Arboviral diseases and Varicella. The next set of conditions 
will be identified at a later date.  
 
Q: Can jurisdictions use the new HL7 MMGs to send in summary case notifications for specific 
diseases? 
A: No. The new HL7 MMGs are intended for transmitting individual case notifications. NMI 
expects to address an HL7-based mechanism for summary notifications in the future, but the 
current priority is developing guides for individual case notifications. 
 
Any jurisdiction sending summary statistics for specific diseases should continue to do so by 
using their current process.   
 
Q: What is the process for developing MMGs and implementing case notification messages 
based upon those MMGs? 
A: The development of any Message Mapping Guide and implementation of the case 
notification message based upon that MMG is a collaborative process that involves multiple 
teams, both internal and external to CDC. Internal teams include the NNDSS team, messaging 
and vocabulary team, MVPS development and testing teams, state implementation technical 
assistance team, and CDC programs. External groups include health jurisdictions, CSTE, and 
APHL. 
 
CDC deliverables include the Message Mapping Guide, business rules (BRs) for processing data 







The steps in the process of MMG development and case notification message implementation 
are as follows: 
1. Initiation/concept. 
2. Requirements analysis. 
3. Message design and development. 
4. Message reconciliation and finalization. 
5. Pilot testing of MMG. 
6. MVPS application development. 
7. MVPS testing and implementation. 
8. Publication of final MMG.  
 
Q: Why is CDC taking an incremental approach to the development of MMGs? 
A: Due to budgetary, personnel, technical, and other resource constraints, CDC is proceeding 
with NMI—including the development of MMGs—in a phased, incremental manner, with due 
consideration at each step for how to achieve the most beneficial results in the briefest amount 
of time. 
 
Q: Are MMGS under development available for review? 
A: MMGs that are under development are posted to the NNDSS HL7 Case Notification Resource 
Center at https://wwwn.cdc.gov/nndss/case-notification/.  
 
Jurisdiction public health surveillance staff are encouraged to review and comment on each 
draft MMG when it is open for comment for several weeks on the HL7 Case Notification 
Resource Center. MMGs that have been reconciled with the feedback from their open 
comment periods are also posted to the HL7 Case Notification Resource Center as pilot test-
ready MMGs. 
 
Q: Should jurisdictions use draft message mapping guides to implement surveillance 
information system changes or submit data to CDC? 
A: No. MMGs in Stages I and II are considered draft and may be revised until the time they are 
finalized.  
 
Those jurisdictions selected for pilot testing of the test-ready versions (Stage II) of the MMGs 
should wait until contacted by the NMI TA Team before using the test-ready MMGs, before 
implementing surveillance information system changes, and before submitting test messages to 
CDC.  
 
All other jurisdictions should not plan to submit data to CDC or implement MMG-based updates 
to their surveillance information systems until the final MMGs (Stage III) have been posted.  
 
Q: What diseases will be covered by using the Generic v2 MMG or other HL7 MMGs?   
The National Notifiable Diseases Surveillance System Event Code List, posted under “Related 







https://wwwn.cdc.gov/nndss/case-notification/, should be used by jurisdictions implementing 
HL7 case notification messages to identify all the diseases or conditions (and their respective 
event codes) that should be sent to NNDSS by using the Generic v2 MMG and other HL7 MMGs. 
As new disease-specific MMGs are developed, they will be added to this document. 
 
NOTE: For simplicity in identifying those diseases and conditions that will use the Generic v2 
MMG only, we have filtered this information from the National Notifiable Diseases Surveillance 
System Event Code List and separately posted this information on the NNDSS HL7 Case 
Notification Resource Center as “Conditions to Use Generic v2.0 Only.” This list will be 
produced annually. 
 
The “Event Codes” worksheet in the National Notifiable Diseases Surveillance System Event 
Code List has a “Preferred Mechanism” column that can be filtered by the type of MMG that 
jurisdictions are ready to adopt. If the “Preferred Mechanism” column is filtered by the words 
in the drop-down list specifying “Generic Individual Case Notification v2 (HL7),” then the 
conditions that use only the Generic v2 MMG will be listed and should be sent by using only the 
Generic v2 MMG. Alternatively, if the “Preferred Mechanism” column is filtered by the words in 
the drop-down list specifying “Generic Individual Case Notification v2 with STD Case 





Q: Are all elements of the Generic v2 MMG required?  
A: Not all the data elements in Generic v2 are required. Information on whether a data element 
is required, preferred, or optional is indicated in the draft Generic v2 MMG, available on the 
NNDSS HL7 Case Notification Resource Center at https://wwwn.cdc.gov/nndss/case-
notification/. On the “PHIN Variable IDs” worksheet of the Generic v2 MMG, the column named 
“CDC Priority” indicates the prioritization of the data element by the CDC surveillance program. 
Regardless of whether a data element is considered preferred or optional, jurisdictions should 
map to and send to CDC all the data elements requested in the MMG that they collect in their 
surveillance information systems. 
 
Q: Can jurisdictions continue to submit information in the Generic v1 MMG? 
A: CDC encourages all jurisdictions to transition to the new guides as soon as possible after they 
are published in “Final” (Stage III) status because the new data elements are important for 
notifiable disease surveillance. 
 
Q: Should all diseases be sent by using the Generic v2 MMG? If there are additional 
supplemental data (such as for varicella, mumps, or pertussis when those MMGs are 








A: Eventually, the Generic v2 MMG will be used with all nationally notifiable conditions. 
However, conditions that currently have disease-specific data being sent to CDC through NETSS 
cannot be sent by using the Generic v2 MMG until there is a disease-specific MMG to complete 
the case notification.  
 
Jurisdictions should use the National Notifiable Diseases Surveillance System Event Code List, 
posted under “Related Documentation” on the NNDSS HL7 Case Notification Resource Center 
at https://wwwn.cdc.gov/nndss/case-notification/, to identify which conditions should be sent 
by using each of the new HL7 MMGs. 
 
NOTE: For simplicity in identifying those diseases and conditions that will use the Generic v2 
MMG only, we have filtered this information from the National Notifiable Diseases Surveillance 
System Event Code List and separately posted this information on the NNDSS HL7 Case 
Notification Resource Center as “Conditions to Use Generic v2.0 Only.” This list will be 
produced annually. 
 
Q: For TB, STD and Hepatitis, do jurisdictions need to send Generic v2 messages in addition to 
the disease-specific message? Or will TB, STD, and Hepatitis stand alone and be kept separate 
from the Generic v2 MMG? 
A: The case notification messages for STD and Hepatitis include the data elements from the STD 
and Hepatitis MMGs in combination with the Generic v2 MMG data elements. Jurisdictions 
should not send HL7 TB messages with Generic v2 data elements to MVPS until the TB MMG is 
updated and CDC is ready for jurisdictions to send the revised TB case notifications, which 
include the data elements from the Generic v2 MMG. 
 
Q: How will data reconciliation be done with the new HL7 case notifications? 
A: With MVPS, jurisdictions receive an acknowledgement confirming receipt and parsing of 
messages. A dashboard summarizes data sent by jurisdictions, including the details of messages 
received and processed by CDC, and it flags any warnings or errors. Jurisdictions will be able to 
identify problems and submit corrections to reconcile the data as needed throughout the year. 
 
Q: Will CDC program areas adhere to receiving data in this new way or will they still ask for 
jurisdiction data in Excel or other files? 
A: CDC is working to eliminate the duplication of data requested by CDC in various formats. 
NMI is one part of the CDC Surveillance Strategy, which is coordinating across the agency to 
consolidate systems, eliminate unnecessary redundancies in reporting, and reduce reporting 
burden.  
 
Q: How long will jurisdictions be expected to send case notification messages in both the old 
format plus the new HL7 format? 
A: The period of time where jurisdictions may need to send case notification messages in both 







develop plans for retiring the old format feeds, and CDC can provide technical assistance to 
help with the development of those plans. 
 
 
MESSAGE VALIDATION, PROCESSING, AND PROVISIONING SYSTEM QUESTIONS 
 
Q: What is the MVPS?  
A: The Message Validation, Processing, and Provisioning System, or MVPS, is software that will 
validate and process nationally notifiable disease (NND) case notification messages sent by 
jurisdictions and will provision the data to CDC programs. 
 
Q: Why is the MVPS needed? 
A: The MVPS addresses a number of data processing and distribution challenges. It will allow 
CDC to receive NND data from jurisdictions, process them, and provision them to CDC programs 
more efficiently and effectively than existing systems. The MVPS will provide several benefits to 
jurisdictions and CDC programs: 
• The MVPS will reduce the number of systems processing data at CDC and allow for 
streamlined message processing from jurisdictions to CDC.  
• The MVPS will standardize data processed at CDC. 
• The MVPS will allow CDC programs to receive, process, store, access, share, and analyze 
health-related data, including electronic health record data, to further the agency’s 
public health goals.  
• Through the MVPS Dashboard, the system will provide submitting jurisdictions the 
ability to view the data they have submitted and identify data quality issues. 
 
Q: Describe NNDSS, NEDSS, and NBS. How is the MVPS connected to them in NMI? 
A: The National Notifiable Diseases Surveillance System (NNDSS) is a nationwide collaboration 
that enables all levels of public health—local, state, territorial, federal, and international—to 
share notifiable disease-related health information. Public health uses this information to 
monitor, control, and prevent the occurrence and spread of state-reportable and nationally 
notifiable infectious and noninfectious diseases and conditions.  
 
NNDSS is a multifaceted program that includes the surveillance system for collection, analysis, 
and sharing of health data. It also includes policies, laws, electronic messaging standards, 
people, partners, information systems, processes, and resources at the local, state, territorial, 
and national levels.    
 
Integrated surveillance information systems in reporting jurisdictions that are based on the 
National Electronic Disease Surveillance System (NEDSS) architectural standards are primary 
data sources for NNDSS. Jurisdictions use these information systems to create and send 
standards-based case notifications to CDC for NNDSS. Currently, case notifications can be sent 
using three different standards; CDC’s NNDSS Modernization Initiative will provide a single, new 







The NEDSS Base System (NBS) is a CDC-developed integrated information system that helps 
local, state, and territorial public health departments manage reportable disease data and send 
notifiable disease data to CDC. NBS provides a tool to support the public health investigation 
workflow and to process, analyze, and share disease-related health information. NBS also 
provides reporting jurisdictions with a NEDSS-compatible information system to transfer 
epidemiologic, laboratory, and clinical data efficiently and securely over the Internet. 
Through the NNDSS Modernization Initiative, CDC will replace the existing NNDSS messaging 
infrastructure, but not the NNDSS program, with a message validation, processing, and 
provisioning system—the MVPS—that facilitates the receipt and distribution of notifiable 
disease data. During NMI, jurisdictions will implement HL7 case notification messages and 
MVPS will support collection of data through new guides and a data exchange system that will 
result in more comprehensive, timely, and more accurate information than ever before 
provided to CDC programs.  
 
Q: What is the scope and technology of the MVPS? 
A: The MVPS is a CDC-built and operated message validation, processing, and provisioning 
system. It will validate and process NND messages sent by jurisdictions, provide a data quality 
dashboard, and provision NND data to CDC.  
The MVPS technology includes   
• an integration engine that parses and transforms messages/files and performs vocabulary 
translations and data validations, 
• a business rule management system processing engine, and 
• a database management system that enables provisioning of HL7 and NETSS-formatted data 
for use by CDC programs. 
 
Q: How will CDC programs receive data once the case notifications are sent to CDC?   
A: The MVPS will provision data to the individual CDC programs, and user access to those data 
will be determined by the program. Various options will be available over time, but, initially, 
data will be provided through SQL Server tables and HL7 and NETSS views.  
 
Q: What is data provisioning? 
A: Data provisioning refers to the processes by which surveillance data received through the 
NNDSS are delivered to the disease-specific programs at CDC. It ensures that the necessary data 
relationships and data format are preserved to allow accurate and complete use of the data. It 
also defines the database structures (such as tables and views) that will be used to store the 
data and make them available to programs for analysis and reporting.  
 
Q: What data provisioning process/structure has the MVPS team defined? 
A: Because the data processing and provisioning needs are different for each condition, the 
MVPS team identifies and documents the requirements for each condition. The MVPS team has 







(including content, structural, and business rules) or transformations, and populate the data 
into tables that are accessible by CDC programs. 
 
 
Q: What is the CDC Message Evaluation and Testing Service and why is it needed? 
A: The CDC Message Evaluation and Testing Service (METS) will serve as a common message 
validation service to assist jurisdictions in preparing and sending messages to CDC that adhere 
to the applicable messaging, vocabulary, and programmatic standards. Specifically, METS allows 
jurisdictions to evaluate their test messages as they develop their systems to send HL7 
messages to CDC, ensuring that their systems are generating messages that conform to the 
proper message type structure, business rules, and content.  
 
Q: What is the MVPS Dashboard? 
A: The MVPS Dashboard is a component of the MVPS that displays data sent by jurisdictions, 
including the details of messages received and processed by CDC, as well as warnings and errors 
on messages that were submitted by jurisdictions but do not pass the structural, content, and 
business rules validation. As a result, jurisdictions and programs will be able to use the 
dashboard to verify the number of messages received by CDC and to assist with the 
reconciliation of data throughout the year. In the longer term, MVPS will also provide 
information on which cases were included in the Morbidity and Mortality Weekly Report 
(MMWR), allowing jurisdictions to reproduce counts within MMWR tables and track case 
counts included within MMWR tables. 
 
RETIREMENT OF THE LEGACY NNDSS PORTFOLIO 
 
Q: Will the MVPS supersede NNDSS? 
A: No, the MVPS will not supersede NNDSS. NNDSS is a multifaceted program that includes the 
surveillance system for collection, analysis, and sharing of health data. It also includes policies, 
laws, electronic messaging standards, people, partners, information systems, processes, and 
resources at the local, state, territorial, and national levels. The MVPS is a data exchange 
system that will replace and modernize the current technical infrastructure that supports 
NNDSS. 
 
Q: Can certain disease-specific reporting still use NETSS?  
A: NETSS will be used until all the notifiable conditions have been transitioned to new HL7 
message mapping guides and NETSS can be retired. NETSS retirement is an NMI priority, so, 
although there is not a defined time table, all conditions and jurisdictions will be required to 
transition to the new HL7 case notifications. 
 
Q: What is the strategy for transitioning from legacy data streams to the MVPS? 
A: As MMGs are finalized, jurisdictions are encouraged to implement MMG-based case 








Q: Does CDC have a final cut-off date when it will no longer accept NETSS files? 
A: NETSS retirement is an NMI priority. Jurisdictions will be provided a certain period of time to 
move to the new format, but the final date when NETSS files will no longer be accepted has not 
been determined at this time. However, jurisdictions are encouraged to begin implementing 
the new MMGs when they reach “Final” (Stage III) status. The Health Information Systems 
component of the Epidemiology and Laboratory Capacity (ELC) Cooperative Agreement requires 
demonstrated progress toward the implementation of the new MMGs.  
 
Q: What are the plans for the CDC Data and Message Brokering (DMB) system and the 
Common Data Store (CDS)? 
A: The DMB and CDS systems will be replaced by the MVPS information system. Upon 
successful transition from DMB and CDS to MVPS, the legacy systems will be retired. 
 
USER ACCEPTANCE TESTING 
 
Q: Who will perform user acceptance testing (UAT) and when will it take place? 
A: CDC will ask NMI pilot jurisdictions to assist with testing MVPS releases before they are 
implemented. User acceptance testing will be coordinated between CDC and the pilot 
jurisdictions. This effort will include participation from the MVPS development and testing 
teams, CDC programs, and the NMI technical assistance team.  
 
Six MMGs (Generic v2, STD, Congenital Syphilis, Hepatitis, Mumps, and Pertussis) have been 
prioritized, and each will have an associated UAT timeframe for testing MVPS. The MVPS teams 
will work with CDC programs and the NMI technical assistance team to define time frames and 
support actual testing. 
 
Selected jurisdictions will be asked to participate in two aspects of UAT: 1) formal user 
acceptance testing of the software, and 2) end-to-end testing, which includes provisioning data 
to CDC programs. 
 
 
TECHNICAL ASSISTANCE QUESTIONS 
 
Q: What is the role of technical assistance in NMI? 
A: CDC is partnering with CSTE and APHL to provide and evaluate technical assistance to state 
and local jurisdictions to implement the initial six HL7 case notification messages. Through this 
NMI Technical Assistance Coordination Team, CDC and its partners will help jurisdictions adopt 
the MMGs and use them to send test case notification messages to the MVPS to ensure that 
these messages will be properly received, processed, and stored for analysis through this new 
system. CDC, in collaboration with CSTE and APHL, will provide direct technical assistance and 
training in the form of webinars, online technical guides, and other training materials to 








PILOT JURISDICTION SELECTION  
 
Q: What jurisdictions are serving as pilot sites for NMI? 
A: To help ensure a smooth and translatable technical assistance approach with all jurisdictions, 
the NMI Technical Assistance Coordination Team is piloting both the MMGs and the NMI 
technical assistance approach.   
 
The following states are helping to pilot the Generic v2, Hepatitis, and STD MMGs: Alabama, 
Arkansas, California, Florida, Idaho, Kentucky, Louisiana, Michigan, Minnesota, New York, 
Oregon, Tennessee, and Texas. 
 
It is likely that another set of states will be asked to pilot future guides. 
 
Q: How were jurisdictions selected for the pilot phase of NMI? 
A: In a collaborative effort, the CDC NMI team worked with CDC programs, CSTE, and APHL to 
identify the jurisdictions to pilot the MMGs and technical assistance process. These jurisdictions 
were selected by using several criteria, including a jurisdiction’s technical experience and 
capacity, readiness to participate, scalability of their implementation experience, ability to 
provide feedback on NMI TA tools and resources, and ability to participate in NMI evaluation 
activities.  
 
Q: What activities are NMI pilot site engaged in? 
A: NMI pilot sites are engaged in several activities: 
• adopting and providing feedback on pilot test-ready MMGs; 
• providing feedback on TA tools and resources; 
• testing and providing feedback on the CDC MVPS; and  
• participating in the evaluation of the overall NMI pilot. 
 
GENERAL TECHNICAL ASSISTANCE 
 
Q: What technical assistance will be available?  
A: CDC has partnered with CSTE and APHL to provide technical assistance for the following 
activities: 
• extracting data from surveillance information systems, 
• mapping codes in the data extract to vocabulary specified in the MMGs, 
• creating HL7 messages based on the MMGs by using an integration engine (e.g., 
Rhapsody) or other tools, 
• facilitating secure transport of HL7 messages, and 
• transferring knowledge to enhance in-house capability on the use of integration engines 
and infrastructure management for case notifications to CDC based upon MMGs; and 
• providing education and training to build capacity to use current and future MMGs to 








Q: Can all jurisdictions participate in NMI Technical Assistance?   
A: Yes, all jurisdictions will have the opportunity to participate. The requirement to implement 
HL7 case notification messages, starting with the priority guides, and the availability to request 
technical assistance are both in the Epidemiology and Laboratory Capacity for Infectious 
Diseases (ELC) Cooperative Agreement. Jurisdictions may choose to implement available HL7 
case notification messages on their own as well. Either way, CDC will work with jurisdictions to 
monitor progress through the quarterly ELC Health Information Systems calls. 
 
Q: Is technical assistance system dependent?  
A: No. All jurisdictions can receive technical assistance for HL7 case notification message 
implementation. Jurisdictions using NBS will receive most of their technical assistance from the 
NBS team. Jurisdictions that do not use NBS will receive technical assistance from APHL. 
 
Q: Will there be a cost to the jurisdictions associated with technical assistance?  Will funding 
be provided to help with this process?  
A: No, there is no cost to the jurisdictions for technical assistance. Funding provided in the 
Health Information Systems component of the ELC Cooperative Agreement is intended to help 
jurisdictions implement the messages. When technical assistance is requested, jurisdictions will 
be prioritized based on their readiness and ability to conduct HL7 case notification message 
implementation activities. 
 
Q: When will all jurisdictions be able to adopt the new MMGs? 
A: Once an MMG is finalized (Stage III), all jurisdictions will be invited to adopt the finalized 
MMG, go through onboarding, and send case notification messages to CDC through the MVPS. 
 
Q: Should jurisdictions use draft message mapping guides to implement surveillance 
information system changes or submit data to CDC? 
A: No. MMGs in Stages I and II are considered draft and may be revised until the time they are 
finalized.  
 
Jurisdictions selected for pilot testing of the test-ready versions (Stage II) of the MMGs should 
wait until contacted by the NMI TA Team before using the test-ready MMGs, before 
implementing surveillance information system changes, and before submitting test messages to 
CDC.  
 
All other jurisdictions should not plan to submit data to CDC or implement MMG-based updates 
to their surveillance information systems until the final MMGs (Stage III) have been posted. 
 
Q: How do I submit a technical assistance request?  
A: Once an MMG is finalized, a jurisdiction may request onsite technical assistance by sending 
an e-mail to EDX@cdc.gov and completing a readiness assessment. The assessment will help to 







• type(s) of assistance needed, 
• identification of the guide(s) (Generic v2, STD, Congenital Syphilis, Hepatitis, Mumps, 
Pertussis, etc.), and 
• primary point of contact and contact information. 
FUNDING/COOPERATIVE AGREEMENT 
 
Q: Are NMI and ELC Cooperative Agreement activities two separate projects? 
A: No. Implementing the new MMGs that are developed through NMI is a required activity in 
the Health Information Systems section of the ELC Cooperative Agreement. 
 
Q: What activities are ELC grantees expected to conduct during the current funding cycle 
(August 1, 2014, to July 31, 2018)?   
A: Implementation of HL7 case notification messages developed through the NMI process is a 
requirement for jurisdictions who are receiving health information systems funding through the 
ELC Cooperative Agreement that covers 2014–2018. (Note that implementing the old HL7 
guides does not meet this requirement, and jurisdictions should not invest effort in 
implementing those guides.)   
 
Q: How will grantees report on these activities (monthly, quarterly)? Who will monitor these 
activities?  
A: The quarterly ELC Health Information Systems Implementation Support and Monitoring calls 
with CDC will include updates on HL7 case notification message implementation. The NMI team 
also is working with CSTE to evaluate the NMI effort. Additional details regarding monitoring 
and lessons learned activities will be provided at a later date.  
 
Q: How will CDC success in the NMI effort be measured?   
A: Per the NMI performance objective in the CDC Surveillance Strategy, by 2016, 90% of data 
reported through NNDSS will be by standard HL7 messages.  
 
Q: How will grantee success in the NMI effort be measured?   
A: Grantees will identify a realistic number of priority HL7 case notification messages that they 
will implement in 2014–2018 and, by using these messages, successfully transmit associated 
notifiable diseases data to CDC. 
 
Q: What happens if jurisdictions do not participate in NMI? 
A: Implementation of available HL7 case notification messages developed through the NMI 
process is a requirement for jurisdictions who are receiving Health Information Systems funding 
through the ELC Cooperative Agreement that covers 2014–2018. 
 
CDC understands that jurisdictions not participating in the ELC Cooperative Agreement may 
face circumstances that affect their ability to implement the new HL7 case notification 







forward with NMI so that NNDSS can provide more comprehensive, timely, and higher quality 




NNDSS ONBOARDING QUESTIONS 
 
Q: Is CDC still “certifying” NNDSS messages through PHIN Certification?  
A: No. To foster a more collaborative relationship with jurisdictions submitting NNDSS 
messages, CDC is transitioning to focus on onboarding messages into production and away from 
certification of NNDSS messages through PHIN Certification. 
 
Q: What is the NNDSS onboarding process? 
A: The onboarding process will ensure that jurisdictions transmit data in compliance with the 
NNDSS message mapping guide requirements and that CDC programs are confident in the 
quality of the data that they are receiving.   
 
The NMI team anticipates beginning onboarding for several priority MMGs in 2016. Specific 










GLOSSARY OF TERMS 
 
National Notifiable Diseases Surveillance System (NNDSS): The National Notifiable Diseases 
Surveillance System (NNDSS) is a nationwide collaboration that enables all levels of public 
health—local, state, territorial, federal, and international—to share notifiable disease-related 
health information. Public health uses this information to monitor, control, and prevent the 
occurrence and spread of state-reportable and nationally notifiable infectious and 
noninfectious diseases and conditions.  
 
NNDSS is a multifaceted program that includes the surveillance system for collection, analysis, 
and sharing of health data. It also includes policies, laws, electronic messaging standards, 
people, partners, information systems, processes, and resources at the local, state, territorial, 
and national levels. 
National Electronic Disease Surveillance System (NEDSS): Integrated surveillance information 
systems in reporting jurisdictions that are based on the National Electronic Disease 
Surveillance System (NEDSS) architectural standards are primary data sources for NNDSS. 
Jurisdictions use these information systems to create and send standards-based case 
notifications to CDC for NNDSS. Currently, case notifications can be sent using three different 
standards; CDC’s NNDSS Modernization Initiative will provide a single, new standard to transmit 
data to CDC.  
NEDSS Base System (NBS): The NEDSS Base System is a CDC-developed integrated information 
system that helps local, state, and territorial public health departments manage reportable 
disease data and send notifiable disease data to CDC. NBS provides a tool to support the public 
health investigation workflow and to process, analyze, and share disease-related health 
information. NBS also provides reporting jurisdictions with a NEDSS-compatible information 
system to transfer epidemiologic, laboratory, and clinical data efficiently and securely over the 
Internet. 
National Electronic Telecommunications System for Surveillance (NETSS): Before 
implementing NEDSS, CDC developed and used the National Electronic Telecommunications 
System for Surveillance. The term NETSS refers to a 1) computerized public health surveillance 
information system that provides CDC with weekly data regarding nationally notifiable diseases 
and 2) data file content format for submitting case notifications to CDC. NETSS surveillance 
information systems continue to be used by selected jurisdictions that are transitioning to the 
more robust NEDSS. A bare-bones approach for providing basic data and information, the 
NETSS file content format has not been changed or updated substantially since NETSS launched 
in 1990.  
 
Message Validation, Processing, and Provisioning System (MVPS): The MVPS is software that 
will validate and process nationally notifiable disease data messages sent by jurisdictions and 








The MVPS will provide several benefits to jurisdictions and CDC programs: 
• The MVPS will reduce the number of systems processing data at CDC and allow for 
streamlined message processing from jurisdictions to CDC.  
• The MVPS will standardize data processed at CDC. 
• The MVPS will allow CDC programs to receive, process, store, access, share, and analyze 
health-related data, including electronic health record data, to further the agency’s 
public health goals.  
• Through the MVPS Dashboard, the system will provide submitting jurisdictions the 
ability to view the data they have submitted and identify data quality issues. 
 
 
Have a question about the NNDSS Modernization Initiative that is not answered here? Please send your question to 
edx@cdc.gov for consideration. 
 
